These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28679991)

  • 21. Diagnosis and therapeutic management in a patient with type 2B-like acquired von Willebrand syndrome.
    Karger R; Weippert-Kretschmer M; Budde U; Kretschmer V
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):144-7. PubMed ID: 21178586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Durable remission attained with rituximab therapy in a patient with acquired von Willebrand syndrome associated with CD20-positive lymphoproliferative disorder].
    Kurahashi H; Kawabata Y; Michishita Y; Kitabayashi A; Kobayashi T; Kitadate A; Takahashi N
    Rinsho Ketsueki; 2018; 59(4):420-425. PubMed ID: 29743402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired von Willebrand syndrome: a rare disorder of heterogeneous etiology.
    Kasatkar P; Ghosh K; Shetty S
    J Postgrad Med; 2013; 59(2):98-101. PubMed ID: 23793308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acquired von Willebrand's disease in the course of severe primary hypothyroidism in a patient with autoimmune polyglandular syndrome type 3].
    Lubińska M; Swiatkowska-Stodulska R; Kazimierska E; Sworczak K
    Endokrynol Pol; 2008; 59(1):34-7. PubMed ID: 18335399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired von Willebrand Syndrome in Children.
    Sandrock-Lang K; Glonnegger H; Zieger B
    Hamostaseologie; 2022 Apr; 42(2):117-122. PubMed ID: 35488164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired von Willebrand syndrome in systemic lupus erythematodes.
    Michiels JJ; Schroyens W; van der Planken M; Berneman Z
    Clin Appl Thromb Hemost; 2001 Apr; 7(2):106-12. PubMed ID: 11292186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):577-88. PubMed ID: 16977568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart.
    Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Benk C; Berchtold-Herz M; Trummer G; Schlensak C; Zieger B
    Thromb Haemost; 2010 May; 103(5):962-7. PubMed ID: 20352153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired von Willebrand syndrome associated with Hashimoto's thyroiditis and subcutaneous mucosa-associated lymphoid tissue lymphoma.
    Koyama T; Fujimoto K; Shima M
    Intern Med; 2013; 52(23):2661-3. PubMed ID: 24292759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A two-step approach (Enzyme-linked immunosorbent assay and confirmation assay) to detect antibodies against von Willebrand factor in patients with Acquired von Willebrand Syndrome.
    Franchi F; Biguzzi E; Stufano F; Siboni SM; Baronciani L; Peyvandi F
    Thromb Res; 2014 Dec; 134(6):1316-22. PubMed ID: 25300810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acquired von Willebrand syndrome with autoimmune hemolytic anemia].
    Sakai M; Shima M; Izumi Y; Shirahata A
    Rinsho Ketsueki; 2004 Mar; 45(3):223-7. PubMed ID: 15103936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquired von Willebrand syndrome associated with hypothyroidism: a mild bleeding disorder to be further investigated.
    Federici AB
    Semin Thromb Hemost; 2011 Feb; 37(1):35-40. PubMed ID: 21305800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquired von Willebrand syndrome: features and management.
    Mohri H
    Am J Hematol; 2006 Aug; 81(8):616-23. PubMed ID: 16823821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update.
    Federici AB; Budde U; Castaman G; Rand JH; Tiede A
    Semin Thromb Hemost; 2013 Mar; 39(2):191-201. PubMed ID: 23397553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders.
    Federici AB
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S48-58. PubMed ID: 16427386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic approaches to acquired von Willebrand syndrome.
    Federici AB
    Expert Opin Investig Drugs; 2000 Feb; 9(2):347-54. PubMed ID: 11060681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired von Willebrand syndrome: diagnostic problems and therapeutic options.
    Eikenboom JC; Tjernberg P; Van Marion V; Heering KJ
    Am J Hematol; 2007 Jan; 82(1):55-8. PubMed ID: 16986130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias.
    Dicke C; Schneppenheim S; Holstein K; Spath B; Bokemeyer C; Dittmer R; Budde U; Langer F
    Ann Hematol; 2016 May; 95(6):945-57. PubMed ID: 27040683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
    Geisen U; Zieger B; Nakamura L; Weis A; Heinz J; Michiels JJ; Heilmann C
    Thromb Res; 2014 Aug; 134(2):246-50. PubMed ID: 24891215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired von Willebrand syndrome in a myeloproliferative disorder. Case 6.
    Baud P; Tobler A; Lämmle B; Alberio L
    Hamostaseologie; 2003 Aug; 23(3):121-4. PubMed ID: 12923581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.